Quel est le prix pour CardieX Limited (CDX)

Le prix pour CardieX Limited (CDX) est $0.01754999

Quelle est la capitalisation boursière pour CardieX Limited (CDX)

La capitalisation boursière pour CardieX Limited (CDX) est $2.52M

CardieX Limited (CDX) Prix et Capitalisation Boursière

CardieX Limited, established in Sydney, Australia, in 1994, is a global innovator specializing in the design, production, and distribution of medical devices for cardiovascular health management. Operating across the Americas, Europe, and the Asia Pacific, the company collaborates with pharmaceutical firms by providing its advanced SphygmoCor XCEL devices. It also delivers comprehensive laboratory and data management services, ensuring high-quality datasets for clinical trial sponsors. Under its CONNEQT brand, CardieX develops cutting-edge home vascular health solutions, which encompass remote patient monitoring, tools for decentralized clinical trials, specialized wearables, and medical applications. A flagship product is the CONNEQT Pulse device, a home-based system that leverages proprietary SphygmoCor technology to precisely measure central blood pressure, arterial waveforms, and other vital arterial health parameters. CardieX serves a diverse clientele, including hospitals, clinics, research institutions, and pharmaceutical companies. The company also maintains a strategic alliance with LifeQ, Inc., focusing on wearable device technology. CardieX Limited was formerly known as AtCor Medical Holdings Limited until its name change in June 2018.

Prix pour CDX	L’actif B	La capitalisation boursière de B	Résultats
$37,953.11 $2.52M	NVDA	$5.452T	+216,257,005.08%
$31,257.22 $2.52M	AAPL	$4.490T	+178,103,773.94%
$28,976.54 $2.52M	GOOG	$4.162T	+165,108,471.23%
$25,592.81 $2.52M	MSFT	$3.676T	+145,827,937.67%
$19,722.19 $2.52M	AMZN	$2.833T	+112,377,093.79%

Prix pour CDX

L’actif B

La capitalisation boursière de B

Résultats

$37,953.11 $2.52M